Aspirion acquires AI leader Infinia ML

GEORGIA, UNITED STATES — Aspirion, a leading healthcare revenue cycle management (RCM) provider, has acquired Infinia ML, a renowned artificial intelligence (AI) and machine learning company.

Aspirion manages complex claims and revenue integrity for healthcare systems and hospitals. This acquisition will help boost the firm’s capabilities in intelligent automation for healthcare providers across the United States (U.S.).

“Infinia ML brings the preeminent team of data scientists, strategists, and technologists with extensive AI capabilities and a scalable technology platform with a proven track record of success,” said Amy Amick, CEO of Aspirion.

“Combining Infinia ML’s expertise with Aspirion’s deep RCM experience and market reach, we are uniquely positioned to further elevate revenue cycle performance for our client partners.”

Infinia ML, which will now operate as Aspirion’s research and development engine, has already worked closely with Aspirion before the acquisition. 

Ya Xue, Vice President of Data Science and co-founder of Infinia ML, expressed excitement about the partnership, stating, “The acquisition simply accelerates our ability to create value for Aspirion and its clients.”

“AI technology is rapidly evolving and is a critical driver to unlocking new levels of efficiency, innovation, and insight across the healthcare revenue cycle industry,” said Spencer Allee, Chief AI Officer of Aspirion.

Additionally, Nick Giannasi, a healthcare data and AI veteran, will become the Executive Chairman of Aspirion’s AI group.

This acquisition marks Aspirion’s eighth successful transaction in the past five years.